scispace - formally typeset
E

Ermanno Ciccone

Researcher at University of Genoa

Publications -  92
Citations -  5524

Ermanno Ciccone is an academic researcher from University of Genoa. The author has contributed to research in topics: T-cell receptor & Antigen. The author has an hindex of 39, co-authored 92 publications receiving 5380 citations. Previous affiliations of Ermanno Ciccone include Ludwig Institute for Cancer Research & University of Turin.

Papers
More filters
Journal ArticleDOI

P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities.

TL;DR: Support to the concept that p58 molecules represent a NK receptor delivering a negative signal was provided by experiments in which the entire anti-p58 mAbs could inhibit the lysis of unprotected Fc gamma R- target cells, thus mimicking the inhibitory effect of MHC class I molecules.
Journal ArticleDOI

Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition.

TL;DR: Peptide map analysis indicated that EB6 (or GL183) molecules precipitated from double-positive clones were identical to the corresponding molecules isolated from single-positive ones, thus indicating that the two antigenic determinants are carried by two distinct molecules.
Journal ArticleDOI

Peptide Specificity in the Recognition of MHC Class I by Natural Killer Cell Clones

TL;DR: It is shown that specific self peptides, complexed with MHC class I, provide protection from NK-mediated lysis, and that recognition was peptide-specific.
Journal ArticleDOI

A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function.

TL;DR: Analysis of GL183+ or GL183- NK clones for their ability to lyse human (IGROV I) or murine tumor target cells indicated thatGL183- clones were, on average, fivefold more efficient in inducing target cell lysis.
Book ChapterDOI

Human Natural Killer Cells: Origin, Clonality, Specificity, and Receptors

TL;DR: The ability of activated NK cells to lyse efficiently a wider spectrum of tumor cells can be interpreted as the expression of appropriate activation receptors on these cells as a consequence of cell activation.